Literature DB >> 22200131

A systematic review of the neurocognitive effects of magnetic seizure therapy.

Shawn M McClintock1, Owais Tirmizi, Matthieu Chansard, Mustafa M Husain.   

Abstract

Magnetic seizure therapy (MST) is a novel neurotherapeutic intervention in development for the treatment of major affective disorders. Like other neurotherapeutic strategies such as electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS), a primary interest will be to monitor the associated neurocognitive effects. Thus, the purpose of this systematic review was to synthesize the available data on the neurocognitive effects of MST. The authors performed two independent literature searches with the following terms terms: MST, magnetic, magnetic seizure therapy, depression, neurocognition, cognitive, preclinical. We included in this review a total of eleven articles that mentioned MST and neurocognition in the abstract. The articles were divided into three methodological domains that included virtual computer simulations, preclinical studies, and clinical investigations. Collectively, the available evidence suggests MST has little to no adverse cognitive effects. Specifically, virtual computer simulations found the magnetic field was localized to grey matter, and preclinical studies found no neurocortical or neurocognitive sequelae. Clinical investigations found MST to be associated with rapid reorientation and intact anterograde and retrograde memory. Future investigations using translational methods are warranted to confirm these findings and to further determine the effects of MST on neurocognitive functions.

Entities:  

Mesh:

Year:  2011        PMID: 22200131      PMCID: PMC3638750          DOI: 10.3109/09540261.2011.623687

Source DB:  PubMed          Journal:  Int Rev Psychiatry        ISSN: 0954-0261


  41 in total

1.  Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials.

Authors:  S H Lisanby; D Gutman; B Luber; C Schroeder; H A Sackeim
Journal:  Biol Psychiatry       Date:  2001-03-01       Impact factor: 13.382

2.  A primate model of anterograde and retrograde amnesia produced by convulsive treatment.

Authors:  Tammy D Moscrip; Herbert S Terrace; Harold A Sackeim; Sarah H Lisanby
Journal:  J ECT       Date:  2004-03       Impact factor: 3.635

3.  Early effects of electroconvulsive therapy on cognitive function.

Authors:  Richard Porter; Helen Heenan; Jo Reeves
Journal:  J ECT       Date:  2008-03       Impact factor: 3.635

4.  The cognitive effects of electroconvulsive therapy in community settings.

Authors:  Harold A Sackeim; Joan Prudic; Rice Fuller; John Keilp; Philip W Lavori; Mark Olfson
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

5.  Titrated moderately suprathreshold vs fixed high-dose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects.

Authors:  W V McCall; D M Reboussin; R D Weiner; H A Sackeim
Journal:  Arch Gen Psychiatry       Date:  2000-05

6.  Evaluating storage, retention, and retrieval in disordered memory and learning.

Authors:  H Buschke; P A Fuld
Journal:  Neurology       Date:  1974-11       Impact factor: 9.910

7.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

Review 8.  Introducing magnetic seizure therapy: A novel therapy for treatment resistant depression.

Authors:  Kate E Hoy; Paul B Fitzgerald
Journal:  Aust N Z J Psychiatry       Date:  2010-07       Impact factor: 5.744

9.  Quick recovery of orientation after magnetic seizure therapy for major depressive disorder.

Authors:  George Kirov; Klaus P Ebmeier; Allan I F Scott; Maria Atkins; Najeeb Khalid; Lucy Carrick; Andrew Stanfield; Ronan E O'Carroll; Mustafa M Husain; Sarah H Lisanby
Journal:  Br J Psychiatry       Date:  2008-08       Impact factor: 9.319

10.  Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.

Authors:  Harold A Sackeim; Joan Prudic; Mitchell S Nobler; Linda Fitzsimons; Sarah H Lisanby; Nancy Payne; Robert M Berman; Eva-Lotta Brakemeier; Tarique Perera; D P Devanand
Journal:  Brain Stimul       Date:  2008-04       Impact factor: 8.955

View more
  18 in total

1.  A Review of Brain Stimulation Treatments for Late-Life Depression.

Authors:  Daniel M Blumberger; Jonathan H Hsu; Zafiris J Daskalakis
Journal:  Curr Treat Options Psychiatry       Date:  2015-09-28

2.  Magnetic seizure therapy is efficacious and well tolerated for treatment-resistant bipolar depression: an open-label clinical trial

Authors:  Victor M. Tang; Daniel M. Blumberger; Julia Dimitrova; Alanah Throop; Shawn M. McClintock; Daphne Voineskos; Jonathan Downar; Yuliya Knyahnytska; Benoit H. Mulsant; Paul B. Fitzgerald; Zafiris J. Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2020-09-01       Impact factor: 6.186

Review 3.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.

Authors:  Roumen V Milev; Peter Giacobbe; Sidney H Kennedy; Daniel M Blumberger; Zafiris J Daskalakis; Jonathan Downar; Mandana Modirrousta; Simon Patry; Fidel Vila-Rodriguez; Raymond W Lam; Glenda M MacQueen; Sagar V Parikh; Arun V Ravindran
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

4.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

Review 5.  An overview on clinical aspects in magnetic seizure therapy.

Authors:  Alice Engel; Sarah Kayser
Journal:  J Neural Transm (Vienna)       Date:  2016-06-23       Impact factor: 3.575

6.  Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report.

Authors:  Yoshihiro Noda; Zafiris J Daskalakis; Jonathan Downar; Paul E Croarkin; Paul B Fitzgerald; Daniel M Blumberger
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-31       Impact factor: 2.570

Review 7.  Noninvasive neuromodulation of the prefrontal cortex in mental health disorders.

Authors:  William T Regenold; Zhi-De Deng; Sarah H Lisanby
Journal:  Neuropsychopharmacology       Date:  2021-07-16       Impact factor: 7.853

8.  Applications of transcranial magnetic stimulation and magnetic seizure therapy in the study and treatment of disorders related to cerebral aging.

Authors:  Bruce Luber; Shawn M McClintock; Sarah H Lisanby
Journal:  Dialogues Clin Neurosci       Date:  2013-03       Impact factor: 5.986

Review 9.  Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Authors:  Simone Rossi; Andrea Antal; Sven Bestmann; Marom Bikson; Carmen Brewer; Jürgen Brockmöller; Linda L Carpenter; Massimo Cincotta; Robert Chen; Jeff D Daskalakis; Vincenzo Di Lazzaro; Michael D Fox; Mark S George; Donald Gilbert; Vasilios K Kimiskidis; Giacomo Koch; Risto J Ilmoniemi; Jean Pascal Lefaucheur; Letizia Leocani; Sarah H Lisanby; Carlo Miniussi; Frank Padberg; Alvaro Pascual-Leone; Walter Paulus; Angel V Peterchev; Angelo Quartarone; Alexander Rotenberg; John Rothwell; Paolo M Rossini; Emiliano Santarnecchi; Mouhsin M Shafi; Hartwig R Siebner; Yoshikatzu Ugawa; Eric M Wassermann; Abraham Zangen; Ulf Ziemann; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-10-24       Impact factor: 4.861

10.  Magnetic Seizure Therapy in Treatment-Resistant Schizophrenia: A Pilot Study.

Authors:  Victor M Tang; Daniel M Blumberger; Shawn M McClintock; Tyler S Kaster; Tarek K Rajji; Jonathan Downar; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Front Psychiatry       Date:  2018-01-16       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.